DEF 14A

Company

Pharma-Bio Serv, Inc.

Filed

April 21, 2025

Period of Report

April 12, 2025

Accession Number

0001654954-25-004485

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →